Tikun Olam-Cannbit Pharmaceuticals Ltd

TASE:TKUN 주식 보고서

시가총액: ₪28.0m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Tikun Olam-Cannbit Pharmaceuticals 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Yifat Karib

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기4.1yrs
CEO 소유권n/a
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간4.8yrs

최근 관리 업데이트

Recent updates

Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Has Debt But No Earnings; Should You Worry?

Jun 21
Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Has Debt But No Earnings; Should You Worry?

Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Apr 28
Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Risks To Shareholder Returns Are Elevated At These Prices For Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)

Jul 21
Risks To Shareholder Returns Are Elevated At These Prices For Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)

Would Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Be Better Off With Less Debt?

Oct 03
Would Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Be Better Off With Less Debt?

Is Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Weighed On By Its Debt Load?

Jun 03
Is Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Weighed On By Its Debt Load?

Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Is Carrying A Fair Bit Of Debt

Oct 17
Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Is Carrying A Fair Bit Of Debt

Is Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Using Debt Sensibly?

May 19
Is Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Using Debt Sensibly?

Shareholders Of Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Must Be Happy With Their 135% Total Return

Mar 19
Shareholders Of Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Must Be Happy With Their 135% Total Return

How Much Did Tikun Olam - Cannbit Pharmaceuticals'(TLV:TKUN) Shareholders Earn From Share Price Movements Over The Last Five Years?

Dec 02
How Much Did Tikun Olam - Cannbit Pharmaceuticals'(TLV:TKUN) Shareholders Earn From Share Price Movements Over The Last Five Years?

CEO 보상 분석

Yifat Karib 의 보수는 Tikun Olam-Cannbit Pharmaceuticals 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Dec 31 2023n/an/a

-₪89m

Sep 30 2023n/an/a

-₪98m

Jun 30 2023n/an/a

-₪107m

Mar 31 2023n/an/a

-₪77m

Dec 31 2022₪674k₪582k

-₪48m

Sep 30 2022n/an/a

-₪38m

Jun 30 2022n/an/a

-₪27m

Mar 31 2022n/an/a

-₪30m

Dec 31 2021₪850k₪565k

-₪33m

보상 대 시장: IL 시장에서 비슷한 규모의 회사에 비해 Yifat 의 총 보상이 합리적인지 여부를 입증하기에는 데이터가 부족합니다.

보상과 수익: Yifat 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Yifat Karib (51 yo)

4.1yrs

테뉴어

₪674,000

보상

Ms. Yifat Karib is CEO from March 27, 2023, VP of Marketing & Government Relations from June 01, 2020 at Tikun Olam-Cannbit Pharmaceuticals Ltd respectively.


이사회 구성원

이름위치테뉴어보상소유권
Erez Navon
Director5.1yrs데이터 없음2.7%
₪ 754.8k
Eitan Eliyahu
Chairman of the Board5.1yrs₪505.00k데이터 없음
Yaron Naor
Director5.1yrs데이터 없음10.51%
₪ 2.9m
Yitzhak Ashkenazi
Independent Director4.8yrs데이터 없음0.060%
₪ 16.8k
Orly Zilberman
Independent External Director3.3yrs데이터 없음데이터 없음
Ellit Mann Bitton
Independent External Director2.9yrs데이터 없음데이터 없음
Adi Zvulun
Director1.8yrs데이터 없음데이터 없음

4.8yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 이사회: TKUN 의 이사회경험(평균 재직 기간 4.7 년)으로 간주됩니다.